Breakthrough Chemistry, Inc. (BKTH)
0.208
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Breakthrough Chemistry Research and Development Expense (Annual) : 0.0042M for March 31, 2026
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0042M |
| March 31, 2025 | 0.0013M |
| March 31, 2024 | 0.0054M |
| March 31, 2023 | |
| March 31, 2022 | |
| March 31, 2021 | |
| March 31, 2020 | |
| March 31, 2019 | |
| July 31, 2014 | |
| July 31, 2013 | 0.00 |
| Date | Value |
|---|---|
| July 31, 2012 | 0.00 |
| July 31, 2011 | 0.0019M |
| July 31, 2010 | 0.00 |
| July 31, 2009 | 0.00 |
| July 31, 2008 | 0.00 |
| July 31, 2007 | 0.00 |
| July 31, 2006 | 0.00 |
| July 31, 2005 | 0.00 |
| July 31, 2004 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cardiac Biotech Solutions, Inc. | 0.0275M |
| Precision Optics Corp., Inc. | 1.158M |
| Petros Pharmaceuticals, Inc. | -- |
| RxSight, Inc. | 38.55M |
| Vyome Holdings, Inc. | 0.5883M |